CompletedNCT00936299
Bupropion for teens with ADHD and substance use
About this title
Read the official source — NCT00936299Medication studyAges 13–19United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 13 years to 19 years.
- Listed locations
- DenverSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJanuary 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 105
- Sponsor
- University of Colorado, Denver
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 13 Years to 19 Years
- Official registry ID
- NCT00936299
- Official title
Show the full official title
Bupropion for ADHD in Adolescents With Substance Use Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Denver
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Colorado, Denver, a university.
Did this study involve medication?
Yes. The study involved medication, including Bupropion.
Who was this study for?
Listed age limits: 13 years to 19 years.
